Use este identificador para citar ou linkar para este item:
http://repositorio.ufla.br/jspui/handle/1/41546| Título : | Drug repositioning is an alternative for the treatment of coronavirus COVID-19 |
| Autor: | Serafin, Marissa B. Bottega, Angelita Foletto, Vitória S. Rosa, Taciéli F. da Hörner, Andreas Hörner, Rosmari |
| Palavras-chave: | COVID-19 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) |
| Publicador: | Elsevier |
| Data da publicação: | Jun-2020 |
| Referência: | SERAFIN, M. B. et al. Drug repositioning is an alternative for the treatment of coronavirus COVID-19. International Journal of Antimicrobial Agents, [S.l.], v. 55, n. 6, June 2020. |
| Abstract: | Given the extreme importance of the current pandemic caused by COVID-19, and as scientists agree there is no identified pharmacological treatment, where possible, therapeutic alternatives are raised through drug repositioning. This paper presents a selection of studies involving drugs from different pharmaceutical classes with activity against SARS-CoV-2 and SARS-CoV, with the potential for use in the treatment of COVID-19 disease. |
| URI: | https://www.sciencedirect.com/science/article/pii/S0924857920301266 http://repositorio.ufla.br/jspui/handle/1/41546 |
| Idioma: | en_US |
| Aparece nas coleções: | FCS - Artigos sobre Coronavirus Disease 2019 (COVID-19) |
Arquivos associados a este item:
Não existem arquivos associados a este item.
Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.